CONMED Corporation (NASDAQ:CNMD) shares have been an average broker rating (ABR) of 2.29 at Zacks Research. This is based on a simplified scale taking into account the recommendations posted by 6 research firms covering the stock, tracked by Zacks. A stock with a low ABR (1 or 2) means that is either rated a Buy or Strong Buy on a consensus basis. A stock with a higher ABR (3-5) typically means analysts recommending to Hold or Sell. Three months ago the stock’s ABR was at 2.29, which gives a glance at which direction the sentiment is headed.
The research analysts covering the equity also have issued future price target predictions for the company. On a consensus basis, Wall Street sees the stock going to $60.166 within the year. The most aggressive analyst sees the stock reaching $71 which the most conservative has their target at $51.